Li Rong, female, born October 1974, currently serves as Vice President of Peking University Third Hospital and Director of the Department of Reproductive Medicine. She concurrently holds positions as Chair-Elect of the Reproductive Medicine Branch of the Chinese Medical Association and Vice President of the Asia-Pacific Society for Reproductive Medicine (ASPIRE). She is a recipient of the National Science Fund for Distinguished Young Scholars. Dedicated to advancing clinical applications and fundamental research addressing declining female fertility, she investigates the pathophysiological mechanisms underlying endometrial function establishment, embryo implantation, and pregnancy maintenance. Her work has uncovered novel mechanisms by which reproductive endocrine disorders impact endometrial receptivity. Utilizing multidisciplinary cutting-edge technologies, she has identified key target molecules regulating endometrial receptivity, developed novel multi-level clinical approaches for improving and treating various endometrial disorders, optimized assisted reproductive technology strategies, and significantly enhanced clinical efficacy in treating female subfertility. As first or corresponding author (including co-authorship) published 126 SCI articles in top-tier international biomedical journals such as The Lancet, NEJM, Nature, Nature Genetics, and Human Reproduction, with 2,419 citations. Edited 13 monographs including the nationally key publication Diagnosis and Treatment of Reproductive Endocrine Disorders. She has secured 37 patents, with 15 achievements commercialized at a value of 10.5 million yuan. Contributed to two international reproductive guidelines and spearheaded 19 Chinese expert consensus statements and guidelines. Received three Second Prizes of the National Science and Technology Progress Award, one Second Prize of the National Natural Science Award, one Second Prize of the Ministry of Education's Higher Education Science and Technology Progress Award, and one First Prize of the National Maternal and Child Health Science and Technology Progress Award.

Vice President, Asia-Pacific Society for Reproductive Medicine

President-Elect, Reproductive Medicine Branch, Chinese Medical Association

Secretary, National Expert Panel on Quality Management of Assisted Reproductive Technology

Director, Beijing Center for Quality Control and Improvement of Human Assisted Reproductive Technology

Chairperson, Reproductive Medicine Branch; Vice Chairperson, Reproductive Infection and Microbiome Branch, China Association for International Exchange of Medical and Health Care

Vice Chairperson and Secretary-General, Reproductive Medicine Professional Committee, Chinese Medical Doctor Association

Chairperson, Reproductive Medicine Branch, Beijing Medical Association

2024: Second Prize, National Natural Science Award

2022: Peking University Teaching Excellence Award, Beijing Municipal Science and Technology Progress Award (First Class)

2021: Maternal and Child Health Science and Technology Progress Award (First Class)

2019: Ministry of Education Science and Technology Progress Award (Second Class)

2018: 21st Mao Yisheng Beijing Youth Science and Technology Award

2017: National Science and Technology Progress Award (Second Class), National Maternal and Child Health Science and Technology Award (Second Class)

2016 Huaxia Medical Science and Technology Progress Award, First Class

2015 Beijing Municipal Science and Technology Progress Award, First Class

2014 Higher Education Institution Science and Technology Progress Award, First Class

2013 Huaxia Medical Science and Technology Award, Second Class

2011 National Science and Technology Progress Award, Second Class; Beijing Municipal Science and Technology Progress Award, Second Class

2009 National Science and Technology Progress Award, Second Class

2008 Ministry of Education Higher Education Institution Science and Technology Progress Award, First Class

1. National Natural Science Foundation of China, Center for Basic Science Project (82288102) Female Reproductive Aging and Fertility Remodeling; Jan 2023–Dec 2027, Core Member

2. 14th Five-Year Plan National Key RESEARCH AND DEVELOPMENT Program (2022YFC2702500) Precision Diagnosis and Treatment of Endometrial Receptivity Disorders and Prevention of Related Implantation Failure Diseases; 2022/12/1–2025/11/30, Principal Investigator

3. National Key RESEARCH AND DEVELOPMENT Program of China (2021YFC2700601) Screening Technologies and Intervention Research for Monogenic Pathogenic Variants/Chromosomal Aberrations in Assisted Reproductive Cohorts; 2021/12/1–2024/11/30, Core Member

4. National Natural Science Foundation of China General Program (81771650) Mechanistic Study of miR-125b and Its Targeted circRNA in Regulating Endometrial Function in Polycystic Ovary Syndrome Patients; 2018–2021, Principal Investigator

5. National Key RESEARCH AND DEVELOPMENT Program (2016YFC1000201) Establishment and Applied Basic Research of Assisted Reproductive Population Cohorts and Offspring in the Chinese Population; 2016-2020, Principal Investigator

6. National Natural Science Foundation of China (NSFC) General Program (81471427) Molecular Mechanisms of CD36 in Regulating Lipid Metabolic Abnormalities in Women with Polycystic Ovary Syndrome; Jan 2015–Dec 2018, Principal Investigator

7. 12th Five-Year Plan National Science and Technology Support Program (2012BAI32B01) Research and Demonstration of Comprehensive Intervention Models for Reproductive Health Assessment in the Fertile Population; 2012–2016, Principal Investigator

National Population and Family Planning Commission Science and Technology Department Project (2011-GJKJS-05) Clinical Study on Ziguizhen Capsules for Treating Infertility Due to Thin Endometrium; 2011–2012, Principal Investigator

1. Xie H, An C, Bai B, Luo J, Sun N, Ci B, Jin L, Mo P, Lu Y, Zhong K, Yu Y*, Tan T*, Li R*, Fan Y*. Modeling early gastrulation in human blastoids with DNA methylation patterns of natural blastocysts. Cell Stem Cell. 2025;32(3):409-425.e8.

2. Wang M, Liu Y, Sun R, Liu F, Li J, Yan L, Zhang J, Xie X, Li D, Wang Y, Li S, Zhu X, Li R*, Lu F*, Xiao Z*, Wang H*. Single-nucleus multi-omic profiling of human placental syncytiotrophoblasts identifies cellular trajectories during pregnancy. Nat Genet. 2024;56(2):294-305.

3. Yun C, Yan S, Liao B, Ding Y, Qi X, Zhao M, Wang K, Zhuo Y, Nie Q, Ye C, Xia P, Ma M, Li R*, Jiang C*, Qiao J*, Pang Y*. The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice. Nat Metab. 2024.

4. Peng T, Yang S, Lian W, Liu X, Zheng P, Qin X, Liao B, Zhou P, Wang Y, Liu F, Yang Z, Ye Z, Shan H, Liu X, Yu Y*, Li R*. Cytoskeletal and inter-cellular junction remodelling in endometrial organoids under oxygen-glucose deprivation: a new potential pathological mechanism for thin endometria. Hum Reprod. 2024;39(8):1778-1793.

5. Wang Y, Zhou P, Shan H, Liu X, Cheng M, Ye Z, Chen X, Liao B, Peng T, Xiao C, Huang Z, Dong Y, Yu Y*, Pan H*, Li R*. Endometrial aging is accompanied by H3K27ac and PGR loss. Nat Aging. 2025;5(5):816-830.